Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 3-Year, Multi-Center, Long-Term Safety (LTS) Study to Evaluate the Safety and Tolerability of TD-1473 in Subjects With Ulcerative Colitis (UC)

NCT03920254 is registered in ClinicalTrials.gov with Theravance Biopharma as lead sponsor.

NCT NCT03920254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03920254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 3-Year, Multi-Center, Long-Term Safety (LTS) Study to Evaluate the Safety and Tolerability of TD-1473 in Subjects With Ulcerative Colitis (UC)
Lead sponsor
Theravance Biopharma
Phase
Phase 2/3
Overall status
Terminated
Start date
July 23, 2020
Completion date
October 27, 2021
Enrollment
46 (actual)
Sites
184

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis (uc)